| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |